“…1). The all final collections were casecontrol studies [3,7,8,10,12,24]. As listed in Table 1, the included studies were 3 for breast cancer, 2 for colorectal cancer, 1 for hepatocellular carcinoma, 1 for esophageal cancer and 1 for Non-Hodgkin lymphoma.…”